Riskpilot← Back to searchSign inGet full accessLORBIVMA AS
ASActiveOrg 927456761Vestsideveien 9E, 3403 LierRental and operating of own or leased real estate · NACE 6820Est. 20210 employees
Revenue 2024
NOK 0
EBITDA margin
—
-16% vs 2023
Equity ratio
98.0%
Financial strength
Net profit 2024
NOK -14K
+7% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -13K | -16% |
| Net profit | NOK -14K | +7% |
| Total assets | NOK 1M | +0% |
| Equity | NOK 980K | -1% |
| Employees | 0 | — |
Legal name
LORBIVMA AS
Org number
927456761
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
28. juli 2021
Share capital
NOK 1 020 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Erverv og drift/salg av fast eiendom, deltagelse i andre foretak og det som naturlig står i forbindelse hermed. Samt investeringer og aksjer.
Address
Vestsideveien 9E, 3403 Lier
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | −6 | −8 | −12 | −13 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −6 | −8 | −12 | −13 |
| Net financials | 0 | 0 | −0 | −1 |
| Profit before tax | −6 | −8 | −12 | −14 |
| Tax | −1 | −2 | 3 | −0 |
| Net profit | −5 | −6 | −15 | −14 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 1 015 | 1 009 | 1 000 | 1 000 |
| Equity | 1 015 | 1 009 | 994 | 980 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 6 | 20 |
| Total debt | 0 | 0 | 6 | 20 |
EBITDA margin
-1342500.0%
This company
15.8%
Market median
-8496935% vs market
20212024
Equity ratio
98.0%
This company
38.2%
Market median
+157% vs market
20212024
Return on equity
-1.4%
This company
18.4%
Market median
-108% vs market
20212024
Net profit margin
-1403000.0%
This company
8.1%
Market median
-17321088% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-06-01 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RH Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Narragansett Invest As | Company | 25.0% | 25.0% | 2022 |
Ruba Invest As | Company | 25.0% | 25.0% | 2022 |
| Individual | 12.5% | 12.5% | 2022 | |
| Individual | 12.5% | 12.5% | 2022 | |
Arco Interpharma As | Company | 12.5% | 12.5% | 2022 |
Wike Invest As | Company | 12.5% | 12.5% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LORBIVMA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rune Halstensen | Chief Executive Officer | 0 companies |
| Barbara Halstensen | Board of Directors | 0 companies |
| Lars Birkeland | Chairman | 0 companies |
| Barbara Baklarz | Board of Directors | 0 companies |
| Audun Wike | Board of Directors | 0 companies |
| Vibeke Johansen | Board of Directors | 0 companies |